drugset

drugset / Trial / NCT01459601

Cabergoline Effect on Blood Sugar in Type 2 Diabetics

NCT01459601 ↗

Unknown 10 enrolled Mashhad University of Medical Sciences

RandomizedSingle-groupSingle-blindTreatment

Summary

Diabetic patients with poorly control blood sugar are prescribed cabergoline for 1 months and their blood glucose is evaluated.

Timeline

Start: 2012-01
Primary completion: 2012-02
Completion: 2012-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cabergoline	Small molecule	0.5 mg	—

Indications